Entry Detail



General Information

Database ID:exR0089782
RNA Name:hsa-miR-34c-5p
RNA Type:miRNA
Chromosome:chr11
Starnd:+
Coordinate:
Start Site(bp):111513451End Site(bp):111513473
External Links:hsa-miR-34c-5p



Disease Information

Disease Name:Preterm Birth
Disease Category:Urogenital Diseases and Pregnancy Complications
MeSH ID:D047928
Type:Diseases Category/Female Urogenital Diseases and Pregnancy Complications
Alias:Premature Birth//Birth, Premature//Births, Premature//Premature Births//Preterm Birth//Birth, Preterm//Births, Preterm//Preterm Births



Expression Detail

GEO ID:GSE106224
Description:Exosomal RNA may reflect placenta deficiencies and provide better biomarker in preterm birth
Experimental Design:Disease vs Control
Case Disease Type:Preterm Birth
Case Disease SubType:NA
Case Sample:Preterm Birth
Control Sample:Control
Number of Case:20
Number of Control:50
Number of Samples:70





Regulatory Relationship

mRNA targets:
Gene SymbolChromosomeStart Site(bp)End Site(bp)Strand
ZDHHC17
chr12
76763588
76853696
+
PHF19
chr9
120855651
120894896
-
CD151
chr11
832887
839831
+
ATXN7L3
chr17
44191805
44200113
-
TNRC6B
chr22
40044817
40335808
+
GATAD2B
chr1
153789030
153923360
-
SEC61A1
chr3
128051641
128071683
+
NFAT5
chr16
69565094
69704666
+
NPTX1
chr17
80466834
80477843
-
TMEM109
chr11
60914158
60923443
+
SUPT6H
chr17
28662198
28702679
+
ARPP19
chr15
52547045
52569883
-
PXDC1
chr6
3722614
3752026
-
TRIO
chr5
14143342
14532128
+
AGTRAP
chr1
11736084
11754802
+
NCOA1
chr2
24491914
24770702
+
JRK
chr8
142657460
142681968
-
TOB2
chr22
41433494
41446801
-
NFKBIA
chr14
35401511
35404749
-
ANGEL1
chr14
76786168
76826246
-
MTMR9
chr8
11284816
11328146
+
AMER1
chrX
64185117
64205708
-
NECTIN1
chr11
119623408
119729200
-
MRPL19
chr2
75646783
75690851
+
IGSF3
chr1
116574399
116667755
-
FOSL1
chr11
65892049
65900573
-
TKFC
chr11
61333210
61353295
+
CRTC3
chr15
90529923
90645345
+
FGFRL1
chr4
1009936
1026898
+
ZIC5
chr13
99962964
99971909
-
miRNA targets:NA
circRNA targets:
circRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
hsa_circ_0001723
chr7
91924202
91948826
+
hsa_circ_0001495
chr5
68470703
68471364
+
hsa_circ_0000943
chr19
47421744
47440665
+
hsa_circ_0000038
chr1
28800065
28802803
+
hsa_circ_0001865
chr9
86292641
86293514
-
hsa_circ_0001146
chr20
34241449
34246936
-
hsa_circ_0001164
chr20
45891031
45923523
-
lncRNA targets:
lncRNA SymbolChromosomeStart Site(bp)End Site(bp)Strand
AC018521.1
chr17
47945424
47981736
+
AC116913.1
chr15
66488658
66492109
-
HCG18
chr6
30286690
30327382
-
KCNQ1OT1
chr11
2608328
2699994
-
LINC00665
chr19
36313067
36331770
-
NEAT1
chr11
65422774
65445540
+
SNHG7
chr9
136721366
136728184
-
TERC
chr3
169764520
169765060
-
XIST
chrX
73820649
73852723
-
Display:



Experiment Detail

GEO ID:GSE106224
Sample Source:Blood
Source Fraction:Plasma
Platform:GPL18573
Method:NGS
Num of detected RNA Type:1
Num of detected RNAs of this Type:1522
Sample treatment protocol:Whole blood samples were centrifuged for 15 minutes at 2,000×g at 4°C to get plasma. EVs were isolated from 100 ul of plasma using size exclusion columns (iZON qEV, Cambridge MA) with de-gassed 1X PBS from a total of 22 selected samples, 11 from each group (Table 1). Eluate (~500 ul for each fraction) was collected in microfuge tubes individually. The protein contains and concentration for each fraction were assessed by protein gel electrophoresis and Bradford assay (BioRad, Hercules, CA).
RNA Extract protocol:RNA was isolated from all plasma samples, the 22 EV samples, and 22 corresponding EV-depleted fractions using miRNeasy Micro Kit (Qiagne, Germantown MD).
RNA library preparation protocol:Small RNA sequencing libraries were generated with a modified small RNAseq protocol (manuscript in preparation) that alleviates most of the adapter-miRNA ligation sequence bias problem.



Reference

PMID:29516617
Title:Extracellular vesicle RNAs reflect placenta dysfunction and are a biomarker source for preterm labour
Author:Fallen S, Baxter D, Wu X, Kim TK, Shynlova O, Lee MY, Scherler K, Lye S, Hood L, Wang K
Journal:J Cell Mol Med. 2018 May;22(5):2760-2773.
Description:We have used an improved small RNA library construction protocol and a newly developed size exclusion chromatography (SEC)-based EV purification method to gain a comprehensive view of circulating RNA in plasma and its distribution by analysing RNAs in whole plasma and EV-associated and EV-depleted plasma.